This suggests that SLAMF8 potentiates the TLR4-NF-κB axis, contributing to an immunosuppressive tumor microenvironment and fostering the conditions for metastatic spread, thereby mechanistically linking this immune checkpoint to aggressive disease. This evidence concerns the gene SLAMF8 and neoplasm.